Neurology Central

iPSC therapy success in Parkinson’s monkey models

Researchers from Kyoto University (Japan) have shown that human induced pluripotent stem (iPS) cell-derived dopaminergic (DA) progenitor cells can survive and function as midbrain dopaminergic neurons in a primate model of Parkinson’s disease (PD). The first study of its kind, this new research marks a major breakthrough in bringing iPS cell-based therapies for neurodegenerative disease closer to the clinic.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.